Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients

Endocrine Journal

Volumn 60, Issue 6, 2013, Pages 725-732

  Liu, Jianbin ^a   Liu, Juan ^a   Fang, Donghong ^a   Liu, Liehua ^a   Huang, Zhimin ^a   Wan, Xuesi ^a   Cao, Xiaopei ^a   Li, Yanbing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Continuous subcutaneous insulin infusion; Fasting plasma glucose; Intensive insulin therapy; Remission; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN SENSITIVITY; INSULIN TREATMENT; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREDICTION; RELAPSE; REMISSION; TREATMENT FAILURE;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84879651191     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0315     Document Type: Article

References (21)

1. Ilkova H, Glaser B, Tunckale A, Baqriacik N, Cerasi E (1997) Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 20:1353-1356.
2. Ryan EA, Imes S, Wallace C (2004) Short-term inten-sive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 27: 1028-1032.
3. Li Y, Xu W, Liao Z, Yao B, Chen X, et al. (2004) Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function. Diabetes Care 27: 2597-2602.
4. Weng J, Li Y, Xu W, Shi L, Zhang Q, et al. (2008) Effect of intensive insulin therapy on beta-cell func-tion and glycaemic control in patients with newly diag-nosed type 2 diabetes: a multicentre randomised paral-lel-group trial. Lancet 371: 1753-1760.
5. UKPDS Group (1990) United Kingdom Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. Metabolism 39: 905-912.
6. Leahy JL (2005) Pathogenesis of type 2 diabetes melli-tus. Arch Med Res 36: 197-209.
7. Rossetti L (1995) Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mel-litus. Clin Invest Med 18: 255-260.
8. Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR (1998) Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 15: 290-296.
9. UKPDS group (1995) United Kingdom Prospective Diabetes Study 13: Relative efficacy of randomly allo-cated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 310: 83-88.
10. UKPDS group (1995) United Kingdom prospective dia-betes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44: 1249-1258.
11. Hu Y, Li L, Xu Y, Yu T, Tong G, et al. (2011) Short-term intensive therapy in newly diagnosed type 2 diabe-tes partially restores both insulin sensitivity and β-cellfunction in subjects with long-term remission. Diabetes Care 34: 1848-1853.
12. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, et al. (1976) Relationships between fast-ing plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42: 222-229.
13. Leahy JL, Bonner-Weir S, Weir GC (1992) Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insu-lin secretion. Diabetes Care 15: 442-455.
14. Xu W, Li Y, Deng W, Hao Y, Weng J (2009) Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study. Chin Med J (Engl) 122: 2554-2559.
15. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, et al. (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353: 1454-1462.
16. Nichols GA, Hillier TA, Brown JB (2008) Normal fast-ing plasma glucose and risk of type 2 diabetes diagno-sis. Am J Med 121: 519-524.
17. Tfayli H, Lee S, Arslanian S (2010) Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in chil-dren. Diabetes Care 33: 2024-2030.
18. Dagogo-Jack S, Askari H, Tykodi G (2009) Glucoregulatory physiology in subjects with low-nor-mal, high-normal, or impaired fasting glucose. J Clin Endocrinol Metab 94: 2031-2036.
19. Bi Y, Zeng L, Zhu D, Yan J, Zhang Y, et al. (2012) Association of β-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population. Diabetes Obes Metab 14: 174-180.
20. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29: 717-718.
21. Saisho Y, Butler AE, Manesso E, Galasso R, Zhang L, et al. (2010) Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys. Diabetologia 53: 111-114.